3D CT of Patient Positive for COVID-19 Pneumonia
CT scan and video reveal peripheral, multilobar areas of ground-glass opacity.
Researchers from Pamukkale University Medical School is Turkey have released pictures and a 3D reconstruction video from a 38-year-old COVID-19 patient. They published these results in a March 31 article in Radiology.
The patient, who presented with symptoms, including fever, shortness-of-breath, dry cough, and loss of the sense of smell, that had lasted for three days. He also reported pleuritic chest pain that had lasted for several hours. Although most routine lab values were normal, a lung exam with a stethoscope did reveal a crackling sound.
Upon undergoing an unenhanced chest CT for a preliminary pneumonia diagnosis, the patient’s images revealed peripheral, multilobar areas of ground-glass opacity. This sign suggested a new diagnosis of COVID-19 pneumonia. A subsequent nasopharyngeal swab with real-time polymerase chain reaction (RT-PCR) was also COVID-19-positive, confirming the diagnosis.
The patient was hospitalized and received oxygen inhalation, hydroxycholorquine, oseltamivir, and lopinavir/ritonavir. On day 6, his fever returned to normal, and his clinical symptoms began to show improvement.
Common CT features, according to the researchers, are peripheral, bilateral, multilobar, and basal pre-dominant distributed consolidation and/or ground-glass opacities.
Photon-Counting Computed Tomography: Eleven Takeaways from a New Literature Review
May 27th 2025In a review of 155 studies, researchers examined the capabilities of photon-counting computed tomography (PCCT) for enhanced accuracy, tissue characterization, artifact reduction and reduced radiation dosing across thoracic, abdominal, and cardiothoracic imaging applications.
Can AI Predict Future Lung Cancer Risk from a Single CT Scan?
May 19th 2025In never-smokers, deep learning assessment of single baseline low-dose computed tomography (CT) scans demonstrated a 79 percent AUC for predicting lung cancer up to six years later, according to new research presented today at the American Thoracic Society (ATS) 2025 International Conference.
Can Emerging AI Software Offer Detection of CAD on CCTA on Par with Radiologists?
May 14th 2025In a study involving over 1,000 patients who had coronary computed tomography angiography (CCTA) exams, AI software demonstrated a 90 percent AUC for assessments of cases > CAD-RADS 3 and 4A and had a 98 percent NPV for obstructive coronary artery disease.
